More search options
Basket icon
No items
Basket icon

Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Case
-
Reference no. 9B03N011
Subject category: Entrepreneurship
Authors: James E Hatch (Ivey Business School, Western University); Seema Sindwani (Ivey Business School, Western University)
Published by: Ivey Publishing
Originally published in: 2003
Version: 2009-10-22
Length: 17 pages
Data source: Published sources
Topics: Biotechnology; Venture capital
Share a link: https://casecent.re/p/14565
| No reviews for this item
This product has not been used yet
View our pricing guide or login to see prices.

Abstract

Delex Therapeutics Inc researches and develops drug delivery methods - specifically in pain management - called rapid onset and sustained effect delivery system. The company is seeking funds to support its research and development. A partner at a venture firm that focuses on companies in the health care and biotechnology sectors must assess the investment merits of Delex Therapeutics as it embarks on phase II clinical trials.
Location:
Canada
Industry:
Chemicals and allied products
Size:
Medium
Other setting(s):
2001
Teaching note
-
Reference no. 8B03N11
Subject category: Entrepreneurship
Authors: James E Hatch (Ivey Business School, Western University)
Published by: Ivey Publishing
Originally published in: 2003
Version: 2003-10-08
Length: 9 pages
Data source: Published sources
View full details

About

Abstract

Delex Therapeutics Inc researches and develops drug delivery methods - specifically in pain management - called rapid onset and sustained effect delivery system. The company is seeking funds to support its research and development. A partner at a venture firm that focuses on companies in the health care and biotechnology sectors must assess the investment merits of Delex Therapeutics as it embarks on phase II clinical trials.

Settings

Location:
Canada
Industry:
Chemicals and allied products
Size:
Medium
Other setting(s):
2001

Related

Teaching note
-
Reference no. 8B03N11
Subject category: Entrepreneurship
Authors: James E Hatch (Ivey Business School, Western University)
Published by: Ivey Publishing
Originally published in: 2003
Version: 2003-10-08
Length: 9 pages
Data source: Published sources
View full details